- $275.72m
- $259.75m
- $4.76m
- 47
- 11
- 88
- 47
Annual income statement for XOMA, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 18.4 | 29.4 | 38.2 | 6.03 | 4.76 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 22.3 | 17 | 20.9 | 23.4 | 46.6 |
Operating Profit | -3.88 | 12.4 | 17.2 | -17.4 | -41.8 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -1.98 | 11.8 | 15.9 | -17.1 | -40.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | -1.98 | 13.3 | 15.8 | -17.1 | -40.8 |
Net Income Before Extraordinary Items | |||||
Net Income | -1.98 | 13.3 | 15.8 | -17.1 | -40.8 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1.98 | 9.01 | 7.97 | -22.6 | -46.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.226 | 0.783 | 0.678 | -1.98 | -2.66 |